Medical Media Systems has purchased the assets of GHRL, a Cambridge, MA, provider of validated industry-standard technology for 3D imaging of tumors. As part of the purchasing agreement, the West Lebanon, NH, provider of remote 3D medical imaging and
Medical Media Systems has purchased the assets of GHRL, a Cambridge, MA, provider of validated industry-standard technology for 3D imaging of tumors. As part of the purchasing agreement, the West Lebanon, NH, provider of remote 3D medical imaging and treatment planning applications will also sponsor a National Cancer Institute-funded clinical study to examine whether tumor volume is a better indicator of changes in tumor size and growth than the 2D-based RECIST (response evaluation criteria in solid tumors) protocol that measures the longest diameters of target lesions. The retrospective study, scheduled to begin in early 2004, will be conducted with the Dana Farber Cancer Institute and Harvard Medical School-affiliated hospitals.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.